1.
The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and design
by Fernández-Ortiz, Antonio, MD, PhD
The American heart journal, 2013, Vol.166 (6), p.990-998
2.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
3.
Rationale and Design of F amily-Based A pproach in a M inority Community I ntegrating Systems–Bio l ogy for Promot i on of He a lth (FAMILIA)
by Bansilal, Sameer, MD, MS
The American heart journal, 2017, Vol.187, p.170-181
4.
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
by Fayad, Zahi A, Prof
The Lancet (British edition), 2011, Vol.378 (9802), p.1547-1559
5.
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
by Tawakol, Ahmed, Dr
The Lancet (British edition), 2017, Vol.389 (10071), p.834-845
6.
The BioImage Study: Novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease—study design and objectives
by Muntendam, Pieter, MD
The American heart journal, 2010, Vol.160 (1), p.49-57.e1
